Top Pharma Stocks Set to Trade Ex-Dividend with Potential Returns of 400% & 600%

Rajesh
0

In the fast-paced world of pharmaceutical stocks, investors are always on the lookout for promising opportunities. Zydus Lifesciences Ltd. and Alembic Pharmaceuticals Ltd., two significant players in the pharmaceutical industry, are about to go ex-dividend on July 28, 2023. Both stocks are expected to offer attractive dividends of 400% and 600%, respectively. In this article, we'll delve into the details of these two stocks and their potential for investors.


1. Zydus Lifesciences Ltd.: A Large-cap Pharma Gem

Zydus Lifesciences Ltd., a major player in the pharmaceutical sector, is scheduled to go ex-dividend next week on July 28, 2023, offering an impressive dividend of 600%. The company boasts a substantial market capitalization of Rs 62,458.06 Crore.

On May 18, 2023, Zydus Lifescience's Board of Directors declared a final dividend of Rs 6 per share of Re 1 each, amounting to 600% for the financial year 2022-23. The record date for this dividend is Friday, July 28, 2023, and the payment will be made by August 16, 2023. As per the regulatory filing, the final dividend is subject to approval by the shareholders at the AGM.

Stock Outlook:

As of the latest data, Zydus Lifesciences' stock is trading at Rs 617.05 per share, showing a 1.56% increase compared to its previous close. The stock recently hit a new 52-week high with an intraday high of Rs 618.80 and an intraday low of Rs 605.45 on BSE. Its 52-week high and low stand at Rs 618.80 and Rs 338 per share, respectively.

Over different timeframes, the stock has demonstrated significant gains:

- 1 week: +4.35%

- 1 month: +11.01%

- 3 months: +20.15%

- 6 months: +41.01%

- 1 year: +72.02%

- 3 years: +64.99%

- 5 years: +78.34%


2. Alembic Pharmaceuticals Ltd.: A Midcap Pharma Contender

Alembic Pharmaceuticals Ltd., a prominent midcap player in the pharmaceutical industry, is set to trade ex-dividend on July 28, 2023, with an enticing 400% final dividend. The company holds a market capitalization of Rs 14,021.83 Crore.

On May 05, 2023, Alembic Pharmaceuticals' board fixed the 'Record Date' as July 28, 2023, for the Final Dividend. The company declared a final dividend of Rs 8 per Equity Share with a face value of Rs 2 each, subject to approval by the shareholders at the ensuing Annual General Meeting. The dividend payment is scheduled for August 8, 2023, pending approval at the AGM, which is slated for August 4, 2023.

Stock Outlook:

At present, Alembic Pharmaceuticals' stock is trading at Rs 713.35 per share, registering a 7.68% increase from its previous close. The stock reached an intraday high of Rs 720.55 and an intraday low of Rs 662.45. Its performance over various periods is as follows:

- 1 week: +9.52%

- 1 month: +17.41%

- 3 months: +34.01%

- 6 months: +28.75%

- 1 year: -0.01%

- 3 years: +34.35%


Disclaimer:

Please note that the information provided in this article is solely intended to highlight the upcoming dividends of Zydus Lifesciences Ltd. and Alembic Pharmaceuticals Ltd. It should not be construed as a recommendation to buy, sell, or hold any of the mentioned stocks. The article does not include fundamental or technical analysis, and the author bears no responsibility for any investment decisions made based on this information. Investors are advised to seek guidance from a professional financial advisor before making any investment decisions.

Read Also : Dividend Opportunities in the Chemicals Sector: 2 Small and Mid-Cap Stocks Going Ex-Dividend with Potential High Returns

Tags

Post a Comment

0Comments
Post a Comment (0)